Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) announced that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery (“SRS”) Annual Meeting to be held in Fort Lauderdale, FL, July 23-26.
Of particular note, the Society of Incisionless Surgery (SIS) will also begin its activities as a chapter of SRS by spotlighting a select group of companies (Profound, HistoSonics, Petal Surgical, NVIDIA, Insightec, SurgAR, Brainlab, and Procept BioRobotics) that are helping shape the future of surgery, procedural medicine, and intelligent operating rooms.
Profound’s TULSA-PRO is fundamentally different than traditional mainstream master/slave prostate disease robotic treatment systems as it empowers urologists, really for the first time, to use an autonomous robot under human supervision.
During the inaugural SIS plenary session at SRS2026, Dr. Y. Mark Hong, Medical Director of Integrative Urology in Phoenix, Arizona, is scheduled to deliver a presentation titled “Profound Medical: Incisionless Precision: Imaging, AI, and the Rise of Robotic Autonomy.”
“Profound’s TULSA-PRO represents a fundamentally different approach to traditional robotic surgery,” Dr. Hong said in a statement.
He continued, “By combining real-time MRI guidance, artificial intelligence, and supervised robotic autonomy, the platform enables surgeons to deliver highly personalized treatment based on each patient’s unique anatomy and disease.
TULSA enables physicians to tailor treatment across a continuum of prostate disease, from whole-gland ablation to highly targeted focal therapy and everything in between. That flexibility allows us to personalize care while preserving quality of life whenever clinically appropriate. TULSA’s AI empowers a smoother learning curve and wider adoption while maintaining excellent outcomes with increasing autonomy.
I believe this represents the future of prostate disease treatment, and I am honored to share that vision with the distinguished researchers and clinicians attending SRS2026. I also thank the Society of Incisionless Surgery for the opportunity to participate in this important discussion on the future of robotic and image-guided surgery.”
